Vitae Caps, S.A.

Vitae Caps, S. A. is a company focused on producing high-quality natural ingredients, including Mixed Tocopherols and Vitamin E, enhancing health and wellness across various industries such as food, supplements, and cosmetics. Founded in 2000 and headquartered in Toledo, Spain, Vitae Caps, S.

A. specializes in the production of natural ingredients. In June 2022, the company was acquired by Kensing, a portfolio company of One Rock Capital Partners, which aims to expand Kensing's footprint in Europe and enhance its positioning in the food ingredients sector. The CEO is Juan Rufilanchas.

Vitae Naturals specializes in the production of high-quality natural ingredients, primarily focusing on Mixed Tocopherols, natural Vitamin E, and Phytosterols. These products serve a diverse array of industries, including food and beverage, dietary supplements, cosmetics, and pet food, aiming to enhance the health and wellness of end users. The company's products are designed to act as antioxidants and health enhancers, often incorporated into formulations aimed at improving nutritional profiles or extending shelf life. The company’s offerings are distributed across more than 50 countries worldwide, including significant markets in Europe, North America, and Asia, catering to a broad customer base, including manufacturers, retailers, and direct consumers looking for sustainable health solutions.

In 2022, Vitae Naturals reported a revenue of USD 31. 68 mn and an EBITDA of USD 4. 46 mn. The company generates revenue through a B2B model, supplying its products to manufacturers and wholesalers within various industries.

Transaction structures typically involve bulk orders, allowing clients to integrate Vitae Naturals’ ingredients into their own product offerings, such as supplements and nutraceuticals, with pricing determined based on order volume and product type. Vitae Caps, S. A. plans to leverage the recent acquisition by Kensing to enhance its product offerings and expand into new markets.

The acquisition will support Kensing's growth in the food ingredients industry, specifically targeting European markets for expansion. Details on new products being developed have not been specified, but the company is expected to enhance its product line and market reach following the acquisition completed in June 2022.